Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 EUR | -1.75% | -0.59% | -36.84% |
04-08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-25 | Advicenne: ODD designation in cystinuria | CF |
Sales 2024 * | 4.2M 4.49M 360M | Sales 2025 * | 5.75M 6.15M 492M | Capitalization | 20.63M 22.06M 1.77B |
---|---|---|---|---|---|
Net income 2024 * | -7M -7.48M -599M | Net income 2025 * | 22M 23.52M 1.88B | EV / Sales 2024 * | 10.3 x |
Net Debt 2024 * | 22.7M 24.27M 1.94B | Net cash position 2025 * | 3.2M 3.42M 274M | EV / Sales 2025 * | 3.03 x |
P/E ratio 2024 * |
-2.63
x | P/E ratio 2025 * |
0.82
x | Employees | 21 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.22% |
1 day | -1.75% | ||
1 week | -0.59% | ||
Current month | -19.23% | ||
1 month | -17.85% | ||
3 months | -11.95% | ||
6 months | -3.45% | ||
Current year | -36.84% |
Managers | Title | Age | Since |
---|---|---|---|
Didier Laurens
CEO | Chief Executive Officer | 59 | 02/05/21 |
Chief Tech/Sci/R&D Officer | - | 31/03/23 | |
André Ulmann
BRD | Director/Board Member | - | 22/06/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | 28/04/11 | |
Catherine Dunand
BRD | Director/Board Member | 62 | 08/03/17 |
Didier Laurens
CEO | Chief Executive Officer | 59 | 02/05/21 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.68 | -1.75% | 18,888 |
25/04/24 | 1.71 | +0.59% | 25,060 |
24/04/24 | 1.7 | -0.58% | 20,471 |
23/04/24 | 1.71 | +0.23% | 33,442 |
22/04/24 | 1.706 | +0.95% | 18,055 |
Real-time Euronext Paris, April 26, 2024 at 04:25 pm
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.84% | 22.03M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.35B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- ALDVI Stock